Matches in Nanopublications for { ?s ?p "[Our novel in vitro AKU model allowed us to demonstrate the efficacy of the co-administration of NAC and ASC to counteract the negative effects of HGA for the treatment of ochronotic arthropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP371213.RA86Xw3YQDaACnhPX4N1MpCJjZeEtV4UkaUa_btrSLOcc130_assertion description "[Our novel in vitro AKU model allowed us to demonstrate the efficacy of the co-administration of NAC and ASC to counteract the negative effects of HGA for the treatment of ochronotic arthropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP371213.RA86Xw3YQDaACnhPX4N1MpCJjZeEtV4UkaUa_btrSLOcc130_provenance.
- NP480592.RA3tKXs0_IZ7lwQ80QanCefteokiwjXS46zrfSLzvGsGw130_assertion description "[Our novel in vitro AKU model allowed us to demonstrate the efficacy of the co-administration of NAC and ASC to counteract the negative effects of HGA for the treatment of ochronotic arthropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480592.RA3tKXs0_IZ7lwQ80QanCefteokiwjXS46zrfSLzvGsGw130_provenance.
- NP620725.RA4PE03js9Mmk1K7xd4Zoux-uCxoRjWcZel_621yLpGYU130_assertion description "[Our novel in vitro AKU model allowed us to demonstrate the efficacy of the co-administration of NAC and ASC to counteract the negative effects of HGA for the treatment of ochronotic arthropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620725.RA4PE03js9Mmk1K7xd4Zoux-uCxoRjWcZel_621yLpGYU130_provenance.
- NP188735.RAPNm8pDgBijIX_z4YDVLp3h3b09hI-xwS9Htkta2Qqdc130_assertion description "[Our novel in vitro AKU model allowed us to demonstrate the efficacy of the co-administration of NAC and ASC to counteract the negative effects of HGA for the treatment of ochronotic arthropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP188735.RAPNm8pDgBijIX_z4YDVLp3h3b09hI-xwS9Htkta2Qqdc130_provenance.
- NP609753.RAxUN9iuajXywiWHz2SSHqD0SDK5ZszqWeZXjx3t-CysE130_assertion description "[Our novel in vitro AKU model allowed us to demonstrate the efficacy of the co-administration of NAC and ASC to counteract the negative effects of HGA for the treatment of ochronotic arthropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP609753.RAxUN9iuajXywiWHz2SSHqD0SDK5ZszqWeZXjx3t-CysE130_provenance.
- NP795726.RA24l_lCvI17d55DGCzx-XlYtjU_MPsJhiNNrB-UjXm_A130_assertion description "[Our novel in vitro AKU model allowed us to demonstrate the efficacy of the co-administration of NAC and ASC to counteract the negative effects of HGA for the treatment of ochronotic arthropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP795726.RA24l_lCvI17d55DGCzx-XlYtjU_MPsJhiNNrB-UjXm_A130_provenance.
- NP867627.RAHrS9bn7h7BfIQR5CcGCfZIt-r_9lyyX9qeMUuNEZD68130_assertion description "[Our novel in vitro AKU model allowed us to demonstrate the efficacy of the co-administration of NAC and ASC to counteract the negative effects of HGA for the treatment of ochronotic arthropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867627.RAHrS9bn7h7BfIQR5CcGCfZIt-r_9lyyX9qeMUuNEZD68130_provenance.